TG THERAPEUTICS, INC.: cashflow_financing

Value{"amount": 128527000, "concept": "us-gaap:NetCashProvidedByUsedInFinancingActivities", "currency": "USD"}
Period2024-01-01 – 2024-12-31
Statuscurrent
EntityTG THERAPEUTICS, INC.
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference: 0001437749-25-005908
Retrieved: 2026-08-19T09:42:11.974157+02:00
Raw response sha256: f7bde1a401b286c74a2fd824ee1df541…
Also addressable by official identifiers: https://factanker.com/fact/sec/cik-0001001316/cashflow-financing/2024-12-31 (CIK, metric, reporting date)
Cite as: FACTANKER, https://factanker.com/fact/3974fd80-c9d4-4d7d-a5ac-685d8aa63ea5

History